对BRCA突变患者的新疗法选择
Anthony Ghanem1, Susan M Domchek2,1
1Department of Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA;
Annual review of medicine
|December 4, 2024
概括
在BRCA1和BRCA2基因的致病变体增加癌症风险. 聚ADP-ribose) 聚合酶 (PARP) 抑制剂为这些癌症提供了向治疗,目前正在研究耐药性和更广泛的应用.
科学领域:
- 瘤学 在瘤学方面.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 在BRCA1和BRCA2基因的致病变体显著提高了乳腺,卵巢,胰腺和前列腺癌的风险.
- 这些基因在通过同源重组来修复DNA双链断裂中发挥着至关重要的作用.
研究的目的:
- 讨论聚聚合酶 (PARP) 抑制剂的开发和机制.
- 探索对PARP抑制剂的耐药性机制.
- 检查PARP抑制剂在BRCA1 / 2相关癌症之外的潜在实用性,并审查新药.
主要方法:
- 关于PARP抑制剂开发和临床应用的文献综述.
- 分析BRCA1/2突变癌症中耐药机制的分析.
- 探索新兴的治疗策略和药物.
主要成果:
- PARP 抑制剂已被批准用于多种与BRCA1/2相关的癌症,证明了向治疗疗效.
- 了解BRCA1/2生物学是开发这些向疗法的关键.
- 研究正在扩大PARP抑制剂的应用到其他瘤类型,并研究新型药物.
结论:
- PARP 抑制剂在治疗 BRCA1/2 相关癌症方面取得了重大进展.
- 对抗性机制和扩展治疗应用的进一步研究至关重要.
- 新型药物正在调查中,以改善更广泛患者的治疗结果.
更多相关视频
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
12.2K
08:53Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
14.6K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
01:27Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K